LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

Search

Cencora Inc

Geschlossen

BrancheGesundheitswesen

361.95 -0.89

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

361.18

Max

368.2

Schlüsselkennzahlen

By Trading Economics

Einkommen

-28M

690M

Verkäufe

3.1B

84B

KGV

Branchendurchschnitt

45.868

105.69

EPS

3.84

Dividendenrendite

0.61

Gewinnspanne

0.855

Angestellte

51,000

EBITDA

-1.1B

150M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+8.35% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.61%

2.37%

Nächste Dividendenausschüttung

1. Dez. 2025

Nächstes Ex-Dividendendatum

14. Nov. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

4.6B

71B

Vorheriger Eröffnungskurs

362.84

Vorheriger Schlusskurs

361.95

Nachrichtenstimmung

By Acuity

45%

55%

157 / 374 Ranking in Healthcare

Cencora Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

13. Nov. 2025, 21:34 UTC

Ergebnisse

Applied Materials 4Q Sales Fall; Forecasts Higher Demand in 2H26

13. Nov. 2025, 23:45 UTC

Market Talk

Nikkei May Fall After Wall Street's Weakness -- Market Talk

13. Nov. 2025, 23:42 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 4th Update

13. Nov. 2025, 23:41 UTC

Market Talk

Gold Edges Higher on Possible Dip-Buying -- Market Talk

13. Nov. 2025, 23:24 UTC

Ergebnisse

JBS NV: Robust U.S. Beef Demand Supported 3Q North America Sales >JBS

13. Nov. 2025, 23:24 UTC

Ergebnisse

JBS NV: Live Cattle Prices Have Remained High, Pressuring Profitability >JBS

13. Nov. 2025, 23:23 UTC

Ergebnisse

JBS NV 3Q EPS 52c >JBS

13. Nov. 2025, 23:23 UTC

Ergebnisse

JBS NV 3Q Sales $22.6B >JBS

13. Nov. 2025, 23:04 UTC

Market Talk

RBA Looks Set To Remain Sidelined For a While Yet -- Market Talk

13. Nov. 2025, 22:02 UTC

Ergebnisse

Nu Holdings 3Q Net $783M >NU

13. Nov. 2025, 22:01 UTC

Ergebnisse

Nu Holdings 3Q Rev $4.2B >NU

13. Nov. 2025, 21:51 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 3rd Update

13. Nov. 2025, 21:50 UTC

Ergebnisse

Disney Posts Roughly Flat Quarterly Revenue as TV Declines Continue -- 4th Update

13. Nov. 2025, 21:45 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 2nd Update

13. Nov. 2025, 21:41 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- Update

13. Nov. 2025, 21:36 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Plans to Bid for All of Warner Bros., Sources Say -- WSJ

13. Nov. 2025, 21:36 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount, Comcast, Netflix Among Potential Bidders That Have Looked at Warner Bros. Financials, Sources Say -- WSJ

13. Nov. 2025, 21:36 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- WSJ

13. Nov. 2025, 21:36 UTC

Akquisitionen, Fusionen, Übernahmen

Netflix, Comcast Each Considering Pursuing Warner Bros. Studio, Streaming Assets, Sources Say -- WSJ

13. Nov. 2025, 21:36 UTC

Akquisitionen, Fusionen, Übernahmen

Bids for Warner Bros. Discovery Due Next Week, Sources Say -- WSJ

13. Nov. 2025, 21:33 UTC

Market Talk

Banks See CAD Appreciation Through 2026, Trade Poses 'Clear' Risk -- Market Talk

13. Nov. 2025, 21:33 UTC

Ergebnisse

If Investors Like Rocket Lab Stock, They Should Love Firefly Shares -- Barrons.com

13. Nov. 2025, 21:31 UTC

Ergebnisse

Applied Materials Stock Falls Despite Strong Earnings -- Barrons.com

13. Nov. 2025, 21:25 UTC

Ergebnisse

Figure Tech Solutions 3Q Rev $156.4M >FIGR

13. Nov. 2025, 21:25 UTC

Ergebnisse

Figure Tech Solutions 3Q EPS 34c >FIGR

13. Nov. 2025, 21:23 UTC

Ergebnisse

Intchains Group 3Q Rev $1.3M >ICG

13. Nov. 2025, 21:03 UTC

Ergebnisse

Applied Materials Sees 1Q Rev $6.35B-$7.35B >AMAT

13. Nov. 2025, 21:02 UTC

Ergebnisse

Applied Materials Sees 1Q Adj EPS $1.98-Adj EPS $2.38 >AMAT

13. Nov. 2025, 21:01 UTC

Ergebnisse

Applied Materials 4Q Rev $6.8B >AMAT

13. Nov. 2025, 21:01 UTC

Ergebnisse

Applied Materials 4Q Gross Margin 48.0% >AMAT

Peer-Vergleich

Kursveränderung

Cencora Inc Prognose

Kursziel

By TipRanks

8.35% Vorteil

12-Monats-Prognose

Durchschnitt 393.78 USD  8.35%

Hoch 417 USD

Tief 361 USD

Basierend auf 10 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Cencora Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

10 ratings

9

Buy

1

Halten

0

Sell

Stimmung

By Acuity

157 / 374 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Durchschnitt

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Cencora Inc

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
help-icon Live chat